Good morning :)
$
₹
Elicio Therapeutics Inc.

Elicio Therapeutics Inc.

ELTX

NASDAQ
$1.552.30% (+0.03)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Biotechnology

Micro Cap

With a market cap of $43.1M the stock is ranked 5120

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

5.73
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-2.16
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 4 analysts reports

Buy
3 analysts
Hold
1 analyst
Sell
0 analyst

Price Upside

+759.54%

Earnings Growth

+27.96%

Rev. Growth

—

See Detailed Forecast

Company Profile

Company Profile

P/E Ratio
46.00
46.00
1Y Return
57.43%
57.43%
Buy Reco %
83.87
83.87
P/E Ratio
41.05
41.05
1Y Return
43.8%
43.8%
Buy Reco %
69.56
69.56
P/E Ratio
149.85
149.85
1Y Return
75.37%
75.37%
Buy Reco %
67.85
67.85
P/E Ratio
30.82
30.82
1Y Return
28.58%
28.58%
Buy Reco %
41.66
41.66
P/E Ratio
26.39
26.39
1Y Return
15.24%
15.24%
Buy Reco %
75.00
75.00
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Financials

Financials

Income

Balance Sheet

Cash Flow

-10
-7.7
-11.8
-8.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue0001.16000000
Net Income-11.82-7.22-18.83-14-11.20-10.56-10.08-7.71-11.82-8.21
Net Profit Margin----1201.02%------

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Elicio Therapeutics Inc. -5.73-
Eli Lilly and Company46.0031.351.35
Johnson & Johnson41.058.063.07

Price Comparison

Price Comparison

Compare ELTX with any stock or ETF
Compare ELTX with any stock or ETF
Comparing from
ELTX
LLY
JNJ
Loading...

Frequently asked questions

  1. Elicio Therapeutics Inc. (ELTX) share price today is $1.55 as of November 5, 2026 at 12:24 AM IST. The stock touched a day high of $1.64 and a day low of $1.51.

  2. Elicio Therapeutics Inc. stock trades on NASDAQ under the ticker symbol ELTX.

  3. Elicio Therapeutics Inc.'s market capitalization is $43.07M as of November 5, 2026 at 12:24 AM IST.

  4. Elicio Therapeutics Inc.'s price-to-earnings (P/E) ratio is N/A as of November 4, 2026.

  5. Elicio Therapeutics Inc.'s price-to-book (P/B) ratio is 5.73 as of November 4, 2026.

  6. Yes, You can buy Elicio Therapeutics Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Elicio Therapeutics Inc. shares in three steps: 1. Search Elicio Therapeutics Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Elicio Therapeutics Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Elicio Therapeutics Inc. (ELTX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 6.4308 shares at the current price of $1.55.

Loading...